Ardana appoints Klaus Falk as VP Sales & Marketing

Edinburgh, UK, 17 March 2006;  Ardana plc (LSE:ARA) the emerging pharmaceutical company focused on improving human reproductive health, announces the appointment of Klaus Falk as Vice President, Sales & Marketing.

Mr Falk, aged 46, has over 20 years of experience in the pharmaceutical industry, gained at Merck KGaA in a number of posts including 8 years as a General Manager in Central and South America. Whilst based in Germany, he gained experience in a range of strategic projects including M&A and the company’s IPO in 1995. As Vice President, Europe, he was responsible for Sales & Marketing and his achievements included the successful launch of the oncology franchise’s first product, Erbitux, in 2003.

Commenting, Dr Maureen Lindsay, Ardana’s CEO, said, “Klaus’s deep and broad experience over the last 20 years will bring significant benefits to Ardana as we build further on our sales and marketing capabilities in the UK and Europe.  With Striant on the market; a planned launch for Invicorp later this year, and various in-licensing opportunities, we are delighted that Klaus will be leading these key activities”.

For more information contact:

back to top